The Opioid Epidemic and Maternal Health: Three Opportunities for Change
Opioid use disorder in pregnancy has increased dramatically across the country in the last decade, bringing with it increased health risks for mothers and babies. Mothers who don’t receive treatment are facing increased pregnancy complications, including increased risk for preterm births and low birth rates, and ultimately, more families are being separated, whether by needed social services or the tragic loss of a parent.
“These numbers oblige us to seize every opportunity to support families affected by the opioid crisis,” says NICHQ Chief Health Officer Elizabeth Coté, MD, MPH. “Each encounter a potential mother has with a care system—whether during gynecological care and screening, prenatal care and delivery, postpartum care or well child visits—is an opportunity for advocacy and change. Each encounter is a new chance, a potential moment for change that conveys hope.”
Improving these encounters is one area of focus for the National Network of Perinatal Quality Collaboratives (NNPQC), funded by the Centers for Disease Control and Prevention. NICHQ serves as the coordinating center for the NNPQC , which provides quality improvement expertise to state-based PQCs, helping them drive change in maternal and infant health outcomes across the country. Many of the PQCs in the network have identified opioid use disorder as a critical opportunity for improvement.
Below, we’re sharing ideas from NNPQC faculty experts—Ron Iverson, MD, MPH; Mike Marcotte, MD; Moira Crowley, MD; and Elisha Wachman, MD—on improving three potential encounters at three early stages of motherhood. Improving these interactions, especially for at-risk mothers, translates to more opportunities to help families when they are in crisis and in most need of additional aid.
In giving these families better support and more chances to make a change, public health professionals can better address the opioid epidemic and its damaging effects on maternal and infant health.
Prenatal opportunities: Screening and intervention
A woman’s first prenatal visit is a critical opportunity to screen for opioid use disorder. When the visit is managed well, a care provider can identify a mother’s addiction severity, offer initial information on the risks of continued illicit drug use, advise on next steps, and connect her with the supports she needs to heal (e.g., Medication-Assisted Treatment (MAT) providers, psychiatric care, social workers and local resources). However, without this supportive and compassionate approach, such screenings may be underutilized and ineffective.
“Women may feel nervous or uncomfortable bringing up their substance use,” says Iverson, the director of labor and delivery at Boston Medical Center (BMC). “It’s our job to be proactive about the screening and sensitive about how we respond. Establishing an initial rapport with these families, and acknowledging their unique experiences, brings needed trust.”
Similarly, says Iverson, care providers should never appear caught off guard when a mother discloses her opioid use. Acting surprised or judgmental can leave mothers feeling even more uncomfortable, making them less likely to trust recommendations or follow-up with concerns. Developing a standard plan for intervention helps ensure that providers are always prepared to give relevant, actionable and, perhaps most importantly, judgement-free advice.
Opportunities post-delivery: Empowering caregivers
After delivery, opioid-exposed newborns are often taken to intensive care for pharmacologic treatment, leaving mothers feeling alienated from their babies’ care.
“Rather than inspire change, this approach risks telling a new mother that she’s not capable of caring for her child,” explains Wachman, attending neonatologist at BMC. “We need to instead empower mothers as the primary treatment for their new babies. We can teach them how to console their babies, how to be a constant source of comfort and care.”
When care teams empower mothers on behalf of their own health and the health of their children, they improve long-term outcomes for families, all while helping babies recover at a faster rate. According to Wachman, this “nonpharmacologic” treatment approach—including rooming-in and breastfeeding, if not contraindicated—supports infant recovery and has reduced the length of stay and need for pharmacologic treatment in infants with neonatal abstinence syndrome by half at BMC.
Supporting mothers as caregivers also means being honest about their own treatment. This transparency helps realistically prepare mothers for recovery while establishing a foundation of trust between them and the healthcare system.
“Tell mothers what they can expect during that first hospitalization and prepare them to talk to social services,” says Crowley, the director of neonatal ECMO at the University Hospitals Rainbow Babies and Children’s Hospital in Cleveland. “Offering mothers realistic, honest advice positions you as a trusted ally, whereas letting them get blindsided might make them resistant to care.”
Postpartum opportunities: Supporting the dyad
When mothers return home, they’re often left battling their addiction while taking on the significant additional stress of a newborn. During that first year, relapse rates spike, bringing with them dire consequences.
“In many states, accidental overdose is the leading cause of maternal death in that first year,” says Marcotte, director of quality and safety for women’s services at TriHealth in Cincinnati. “We’re losing too many mothers because they don’t have a support system. We can change that, though, by partnering with pediatricians to help support post-discharge care.”
While a mother may not follow up with her own care, she is likely to follow up with her child’s. Pediatric visits then become critical opportunities to discuss addiction treatment and needs, such as coordinating sub-specialists and social services, and directing mothers to additional community support networks. Forwarding a two-generational approach at these visits—one that prioritizes comprehensive care of the mother-child dyad—provides another critical opportunity to support families, another chance to inspire change.
“We have to remember that these families often face significant barriers to optimal health, such as trauma, poverty and access to healthcare,” says Coté. “Addiction is a chronic disease marked by relapse. But by aligning systems of care and transforming every interaction into an opportunity for change, we’ll come closer to providing these families with the wrap-around services they need to recover and heal.”
3 Ways to Close Gaps in Sickle Cell Disease Care: Recommendations from NICHQ Projects
In the past several decades, clinicians, public health professionals, and those with lived experience have seen advancements in Sickle Cell Disease (SCD) treatments and research that have significantly improved outcomes and increased life expectancies for people living with SCD. For example, the FDA-approved medication hydroxyurea (HU) has been recommended as a SCD standard of care due to its ability to help people with SCD mitigate pain and the need for blood transfusions. Preventative measures, such as screening children and adolescents for risk of stroke and ensuring that all people who have SCD receive recommended vaccinations, have also been instrumental in reducing complications associated with SCD. And recently, development of gene therapies has presented possibilities of a new cure. Conversations on how to improve access to care should continue, and these three recommendations begin with some of the most pressing needs.
Racially Motivated Violence is a Children’s Health Issue
In the wake of recent mass shootings in Buffalo, Uvalde, and Highland Park, and too many others, we discuss the mental health implications of racially motivated and gun violence on children and their families with Stacy Scott, PhD, MPA, Executive Project Director and Equity Lead at NICHQ, and Becky Russell, MSPH, Senior Director of Applied Research and Evaluation at NICHQ.
NICHQ Employee Spotlight: Kenn Harris
Here, NICHQ Executive Project Director and Engagement Lead Kenn Harris shares his experience with the Federal Healthy Start Program and encourages organizations to dive deeper when addressing equity.
To Improve Maternal Health, We Must Depoliticize Racial Equity
Earlier this year, data from the Centers for Disease Control and Prevention (CDC) showed that maternal mortality rates increased during the first year of the pandemic, continuing a decades-long trend of increasing pregnancy-related deaths. With our Joint Organizational Commitment, NICHQ acknowledges that racism is a public health crisis and lays out our commitments to critically analyze and change our organizational systems with the goal of advancing racial equity.
Look for NICHQ at Upcoming Spring Maternal Child Health Conferences
Teams at the National Institute for Children’s Health Quality are preparing for an exciting spring 2022 conference season, where staff will provide keynote addresses, give poster presentations, and facilitate workshops at a variety of national maternal and child health conferences.